1.1.1 — APhA NACDS MTM Elements

1.1.1.3 Foundational structure: what the five MTM elements are and how they fit together

A Explanation

The first exam decision conflict is simple but heavily tested: is the stem asking about the review process, the patient handout, the clinician communication, or the service record? The single rule that resolves it is this: MTR is the assessment; PMR and MAP are patient-facing outputs; intervention/referral is the clinician-facing action; documentation/follow-up closes the loop. If you keep those buckets separate, most introductory MTM questions become straightforward.

WHY THIS IS TESTED: test writers often present one correct clinical idea but ask for the wrong deliverable. For example, a recommendation to obtain renal labs is not itself a MAP item unless written as a patient action; likewise, a medication list is not documentation just because the pharmacist created it.

In practical MTM workflow, the pharmacist begins with a medication therapy review, which may be comprehensive or focused. From that review come patient-facing tools: an accurate PMR and a prioritized MAP. If the pharmacist identifies a problem requiring action by another clinician, intervention or referral follows. The encounter is not complete until documentation captures the problem, recommendation, communication, and follow-up plan. See Fig 1.

B Worked example

A 71-year-old woman with type 2 diabetes, hypertension, and osteoarthritis brings metformin 1000 mg by mouth twice daily, lisinopril 20 mg daily, hydrochlorothiazide 25 mg daily, ibuprofen 400 mg three times daily as needed, and an outdated bottle of glyburide she says she “sometimes still takes.” She reports dizziness and missed meals, but her distracting laboratory value is a stable LDL of 82 mg/dL. During the pharmacist visit, the learner is asked which APhA/NACDS MTM element is best represented by “give the patient a current list of what she should and should not be taking.”

Reasoning chain: identify task → this is not asking for problem identification itself, but for a patient take-home tool. Extract key facts → multiple actual and outdated medications, so the patient needs an accurate medication list. Apply rule → the patient-facing current medication list is the PMR. Eliminate distractors → MAP would list actions such as “stop using old glyburide until clarified” or “call clinic about dizziness”; intervention/referral would be contact with the prescriber; documentation would be the pharmacist record. Verify → the request centers on a current list for patient reference, so PMR is best.

C Exam trap

D Checkpoint

Question: During an MTM visit, a pharmacist identifies duplicate NSAID use and gives the patient an updated list of all prescription and nonprescription products currently being taken. Which MTM element is most directly represented by that take-home list?

1. A. Medication therapy review — Tempting because the list comes from the review, but the review is the assessment process, not the take-home document.
2. B. Personal medication record — Correct because it is the patient-facing, updated medication list intended for ongoing reference.
3. C. Medication-related action plan — Tempting because patient action is important, but this option would list tasks, not the regimen itself.
4. D. Intervention/referral — Tempting because duplicate NSAID use may require prescriber contact, but the question asks about the list given to the patient.

1.1.1.4 MTR as the assessment engine: what the pharmacist is deciding during review

A Explanation

The second decision conflict is choosing between performing a review and acting on the review. The medication therapy review is the core analytic step. It is where the pharmacist collects, reconciles, and evaluates all available medication information to identify medication-related problems involving indication, effectiveness, safety, and adherence. The single finding that resolves many questions is whether the pharmacist is still analyzing the regimen or has already moved to output/action.

WHY THIS IS TESTED: MTM stems often include a clinically interesting issue—duplicate therapy, omitted statin, affordability barrier, or monitoring gap—but the actual question asks which MTM element is being performed. If the pharmacist is still identifying and prioritizing problems, that is MTR.

MTR is broad enough to include medication history verification, assessment of OTC and herbals, review of adherence and affordability, screening for high-risk use, and identification of preventive care gaps tied to medication management. It does not end with merely spotting a discrepancy; the pharmacist must prioritize issues based on urgency, safety, and feasibility. In later lessons, you will separate CMR versus TMR; for now, the key is that both are forms of review under the MTR umbrella. See Fig 2 for how assessment categories feed problem detection.

flowchart TD
A[Medication list and patient interview] --> B{Assess domain}
B --> C[Indication]
B --> D[Effectiveness]
B --> E[Safety]
B --> F[Adherence]
C --> G[Need for therapy? Duplication?]
D --> H[Working? Right intensity?]
E --> I[Interactions? Contraindication? Monitoring?]
F --> J[Cost? Understanding? Access?]
G --> K[Prioritized problem list]
H --> K
I --> K
J --> K

See Fig 2 for the four-domain lens used inside the MTR.

B Worked example

A 63-year-old man with heart failure, atrial fibrillation, and chronic kidney disease presents for an MTM visit after multiple refill gaps. His medications include apixaban 5 mg by mouth twice daily, furosemide 40 mg daily, metoprolol succinate 100 mg daily, and naproxen 220 mg twice daily purchased over the counter. He also reports taking “a water pill from years ago” but cannot identify it. A distracting clue is that he says his multivitamin is “heart healthy.” The pharmacist’s immediate task is to determine which MTM element best describes reviewing all current prescription, OTC, and leftover medications to identify duplicate diuretic use and NSAID-related safety risk.

Reasoning chain: identify task → the pharmacist is evaluating the regimen for problems. Extract key facts → unknown additional diuretic, OTC naproxen, CKD, heart failure, anticoagulant use. Apply rule → this is the medication therapy review. Eliminate distractors → PMR would be the final corrected list; MAP would tell the patient to stop self-adjusting or contact providers; intervention/referral would communicate findings to prescribers; documentation/follow-up would record the encounter. Verify → because the pharmacist is still in the analytic phase, MTR is best.

C Exam trap

D Checkpoint

Question: A pharmacist interviews a patient, reconciles pharmacy claims with pill bottles, and identifies nonadherence to rosuvastatin plus duplication between OTC ibuprofen and prescription meloxicam. Which MTM element is being performed at that moment?

1. A. Medication therapy review — Correct because the pharmacist is actively gathering and assessing information to identify medication-related problems.
2. B. Personal medication record — Tempting because the reconciled information may later populate the PMR, but the step described is assessment, not the handout.
3. C. Medication-related action plan — Tempting because action steps will follow, but the stem has not yet shifted into a patient task list.
4. D. Documentation/follow-up — Tempting because good MTM requires recording the findings, but the current activity is still the review itself.

1.1.1.5 Patient-facing outputs: PMR and MAP are not interchangeable

A Explanation

The most common foundational confusion is mixing the personal medication record with the medication-related action plan. Both are patient-facing, but they solve different problems. The PMR answers: “What medicines am I using?” The MAP answers: “What should I do next?” That single rule resolves nearly every PMR-versus-MAP question.

WHY THIS IS TESTED: Exam stems often include a medication list and a task list in the same vignette. Distractors exploit learners who recognize that the patient needs both but cannot identify which document a given statement belongs in. The PMR should be accurate, current, and understandable to the patient. The MAP should be prioritized, actionable, and written in plain language.

Examples of PMR content include drug name, strength, directions, purpose if helpful, and special notes such as allergies or what the patient actually takes. Examples of MAP content include “Schedule your blood pressure check this week,” “Ask your doctor whether you should continue glyburide,” or “Use a pillbox and bring all medicines to the next visit.” MAP items should be framed as patient actions, not internal clinical commentary. See Fig 3.

flowchart LR
A[Patient-facing item] --> B{Type of content}
B -->|Current medicine list| C[PMR]
B -->|Patient task or follow-up step| D[MAP]
C --> E[Drug name, dose, directions, notes]
D --> F[Call, schedule, bring, monitor, ask, avoid]

See Fig 3 for the fastest test-day rule to separate PMR from MAP.

B Worked example

A 68-year-old man with COPD, coronary artery disease, and insomnia uses tiotropium daily, albuterol inhaler as needed, aspirin 81 mg daily, and diphenhydramine 50 mg nightly purchased over the counter. He reports “sometimes borrowing” his spouse’s omeprazole. The distracting clue is that his blood pressure today is controlled. The pharmacist completes an MTM visit and wants to provide two patient documents: one showing the actual current regimen, and one listing steps such as “stop using your spouse’s medicine,” “bring inhalers to the next visit,” and “ask your clinician about nighttime sleep options.”

Reasoning chain: identify task → two patient-facing outputs are needed. Extract key facts → one need is for an accurate regimen list; the other is for specific follow-up tasks. Apply rule → current regimen = PMR; next steps = MAP. Eliminate distractors → intervention/referral may still occur for anticholinergic burden or unsafe borrowing, but those are separate clinician communications. Verify → if the exam asks which element contains the stepwise patient tasks, the answer is MAP.

C Exam trap

D Checkpoint

Question: Which statement best belongs in a patient’s medication-related action plan rather than the personal medication record?

1. A. Metoprolol succinate 50 mg by mouth once daily for blood pressure — Tempting because it is patient-friendly, but it describes a medication entry and belongs in the PMR.
2. B. Allergic reaction to sulfonamides: rash — Tempting because it is clinically important and may be listed with the PMR, but it is not a patient action step.
3. C. Bring all prescription and over-the-counter medicines to your next visit — Correct because it is a plain-language action the patient should complete.
4. D. Vitamin D 1000 units once daily — Tempting because supplements are often forgotten, but this is still a medication list item for the PMR.

1.1.1.6 Intervention, referral, documentation, and follow-up: closing the MTM loop

A Explanation

The final foundational decision conflict is choosing between educating the patient and taking the next professional action required to resolve the problem. Not every medication-related problem can be solved within the patient conversation alone. If the issue requires a prescriber’s order, diagnostic workup, urgent evaluation, or care-team coordination, the pharmacist must perform intervention/referral. After that, the pharmacist must document the encounter and establish follow-up.

WHY THIS IS TESTED: many stems reward candidates who can recognize when the pharmacist’s role is to recommend, clarify, refer, or escalate rather than independently change therapy. Just as important, many stems test whether follow-up is specific enough to ensure continuity.

Intervention/referral includes communicating suggestions such as dose reassessment, need for lab monitoring, duplicate therapy resolution, refill-gap discussion, or urgent symptom evaluation. Documentation should capture the identified problem, the rationale, who was contacted, what was recommended, patient education provided, and planned follow-up. Follow-up must match risk: a life-threatening issue requires immediate escalation; a routine adherence aid can be reassessed later. See Fig 4 for the decision path. This section is where MTM most clearly intersects with professional scope: the pharmacist acts decisively, but within authority.

flowchart TD
A[Problem identified during MTR] --> B{Can patient self-act safely?}
B -->|Yes| C[Add to MAP and counsel]
B -->|No| D[Intervention or referral]
D --> E{Urgent risk?}
E -->|Yes| F[Immediate escalation]
E -->|No| G[Routine prescriber communication]
C --> H[Document]
F --> H
G --> H
H --> I[Follow-up plan]

See Fig 4 for the choose-versus-escalate logic.

B Worked example

A 76-year-old woman with atrial fibrillation, heart failure, and recent hospital discharge is seen in community MTM. Her list includes warfarin 5 mg nightly, amiodarone 200 mg daily, furosemide 20 mg daily, and trimethoprim-sulfamethoxazole started yesterday at urgent care. She reports gum bleeding and dark stools but says she mainly came in to ask about a calcium supplement. The distracting clue is that she also forgot one warfarin dose last week. The pharmacist must choose the most appropriate MTM action.

Reasoning chain: identify task → urgent safety triage within pharmacist scope. Extract key facts → warfarin plus TMP-SMX interaction, bleeding symptoms, recent discharge, amiodarone interaction. Apply rule → this exceeds simple counseling; urgent evaluation/referral is needed, then documentation and communication. Eliminate distractors → updating the PMR is necessary but not sufficient; adding a MAP item alone delays urgent care; merely documenting without escalation is unsafe. Verify → the highest-priority MTM element now is intervention/referral with immediate escalation, followed by documentation/follow-up.

C Exam trap

D Checkpoint

Question: During an MTM encounter, a pharmacist finds that a patient recently started clarithromycin while taking simvastatin 40 mg nightly and is now reporting new severe muscle pain and weakness. What is the most appropriate MTM element to prioritize first?

1. A. Personal medication record — Tempting because the list needs updating, but it does not address the immediate safety concern.
2. B. Medication-related action plan — Tempting because the patient needs instructions, but clinician-level and urgent action come first.
3. C. Intervention/referral — Correct because a serious interaction with concerning symptoms requires prompt communication and urgent evaluation.
4. D. Documentation/follow-up — Tempting because every encounter must be documented, but documentation follows the urgent safety action.

1.1.1.7 Integration: using the MTM elements to choose the best next step in board-style cases

A Explanation

Once you know the five elements, the board-style challenge becomes integration: which element is the best answer for this exact moment in the case? The resolving rule is to identify the task the pharmacist must complete next, not every reasonable activity that could eventually happen. In most questions, multiple MTM elements are appropriate over the full encounter. The exam asks for the highest-priority next step.

WHY THIS IS TESTED: realistic MTM practice is sequential. A patient may need an MTR, PMR, MAP, prescriber communication, and follow-up—all in one episode. The test discriminates whether you can choose the first necessary action based on urgency, audience, and scope.

A reliable strategy is: identify urgency first; then identify audience; then identify output. If there is immediate danger, choose intervention/referral. If the pharmacist is still detecting problems, choose MTR. If the patient needs a current list, choose PMR. If the patient needs task-oriented instructions, choose MAP. If the question is about defensible recordkeeping or continuity, choose documentation/follow-up. See Fig 5.

flowchart TD
A[Board-style MTM case] --> B{Urgent safety issue?}
B -->|Yes| C[Intervention or referral]
B -->|No| D{Still identifying problems?}
D -->|Yes| E[MTR]
D -->|No| F{Need patient output?}
F -->|Medication list| G[PMR]
F -->|Action steps| H[MAP]
C --> I[Document and follow-up]
E --> I
G --> I
H --> I

See Fig 5 for a compact test-day algorithm.

B Worked example

A 59-year-old woman with diabetes, depression, and recent hospitalization for pneumonia comes for an MTM visit with metformin 1000 mg twice daily, insulin glargine 20 units nightly, sertraline 100 mg daily, and prednisone 40 mg daily started 2 days ago. She forgot her hospital discharge papers and says she might still be taking her old glipizide. Her distracting clue is that she asks whether she should take vitamins with breakfast. The pharmacist identifies possible duplicate diabetes therapy, steroid-related hyperglycemia risk, and uncertainty about what was stopped at discharge.

Reasoning chain: identify task → if asked for the first structured MTM step, the pharmacist must clarify the active regimen and identify problems. Extract key facts → possible duplicate therapy and incomplete discharge information. Apply rule → the best next MTM element is MTR. Eliminate distractors → PMR cannot be accurate until the regimen is verified; MAP would be premature before clarification; intervention/referral may come later if unsafe overlap is confirmed; documentation follows the review. Verify → best answer is the review process first.

C Exam trap

D Checkpoint

Question: A patient asks, “What exactly should I do before my next doctor’s visit?” The pharmacist has already completed medication review, updated the regimen list, and sent a recommendation to the prescriber. Which MTM element best addresses the patient’s question?

1. A. Medication therapy review — Tempting because it generated the findings, but the review phase is already complete.
2. B. Personal medication record — Tempting because the regimen list helps the patient, but the question asks for action steps rather than medication details.
3. C. Medication-related action plan — Correct because it converts findings into specific patient tasks to complete before follow-up.
4. D. Documentation/follow-up — Tempting because the encounter needs closure, but this answer does not directly give the patient next actions.